ArticleJournal of the American Society of Nephrology : JASN2025

Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Discontinuation in Patients with CKD.

L Parker Gregg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.